Stockreport

AGTC Reports Encouraging Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing Phase 1/2 Clinical Trials in Achromatopsia

Applied Genetic Technologies Corporation  (AGTC) 
Last applied genetic technologies corporation earnings: 2/5 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agtc.com/investor-relations
PDF –Encouraging preliminary signs of biologic activity and a favorable safety profile are outcomes that are clinically relevant to patients – Enrollment ongoing in additio [Read more]